Open Access Green as soon as Postprint is submitted to ZB.
Dynamic, helminth-induced immune modulation influences the outcome of acute and chronic hepatitis B virus infection.
J. Infect. Dis. 221, 1448-1461 (2020)
Background. Chronic hepatitis B develops more frequently in countries with high prevalence of helminth infections. The crosstalk between these 2 major liver-residing pathogens, Schistosoma mansoni and hepatitis B virus (HBV), is barely understood.Methods. We used state-of-the-art models for both acute and chronic HBV infection to study the pathogen-crosstalk during the different immune phases of schistosome infection.Results. Although liver pathology caused by schistosome infection was not affected by either acute or chronic HBV infection, S mansoni infection influenced HBV infection outcomes in a phase-dependent manner. Interferon (IFN)-gamma secreting, HBV- and schistosome-specific CD8 T cells acted in synergy to reduce HBV-induced pathology during the T(H)1 phase and chronic phase of schistosomiasis. Consequently, HBV was completely rescued in IFN-gamma-deficient or in T(H)2 phase coinfected mice demonstrating the key role of this cytokine. It is interesting to note that secondary helminth infection on the basis of persistent (chronic) HBV infection increased HBV-specific T-cell frequency and resulted in suppression of virus replication but failed to fully restore T-cell function and eliminate HBV.Conclusions. Thus, schistosome-induced IFN-gamma had a prominent antiviral effect that outcompeted immunosuppressive effects of T(H)2 cytokines, whereas HBV coinfection did not alter schistosome pathogenicity.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
5.022
1.307
5
5
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Coinfection ; Hepatitis B ; Immunomodulation ; Liver ; Schistosoma Mansoni; Regulatory T-cells; C Virus; Schistosomiasis; Liver; Mice; Replication; Coinfection; Prevalence; Responses
Language
english
Publication Year
2020
Prepublished in Year
2019
HGF-reported in Year
2019
ISSN (print) / ISBN
0022-1899
e-ISSN
1537-6613
Quellenangaben
Volume: 221,
Issue: 9,
Pages: 1448-1461
Publisher
Oxford University Press
Publishing Place
Journals Dept, 2001 Evans Rd, Cary, Nc 27513 Usa
Reviewing status
Peer reviewed
Institute(s)
Institute of Virology (VIRO)
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Immune Response and Infection
PSP Element(s)
G-502700-003
G-502700-001
G-502700-001
WOS ID
WOS:000536512000010
Scopus ID
85083881306
PubMed ID
31875228
Erfassungsdatum
2020-01-10